Hofseth BioCare ASA: NEW STUDY SHOWS CALGO® IS SUPERIOR TO TRADITIONAL CALCIUM SOURCES ON OSTEOBLAST AND CALCIUM DEPOSITION

Hofseth BioCare ASA (HBC) produces CalGo®, a microcrystalline hydroxyapatite form of calcium, which is a highly bioavailable calcium supplement with more than 24 % fish bone collagen.
 
Calcium is an essential mineral that supports bone and joint health. It is used as a supplement, most typically as calcium carbonate, to assist in preserving bone density especially when dietary calcium intake is inadequate. In the present study we examined the effect of five varied calcium sources, three natural and two synthetic, on stimulation, proliferation and mineralization of cultured human osteoblast cells.
 
A recent In Vitro Study on the Effect of Five Commercial Calcium Supplements on Human Osteoblast Cell Proliferation and Ca2+ Mineralization has been published in the Journal of Nutrition & Food Sciences (J Nutr Food Sci 8: 738. doi: 10.4172/2155-9600.1000738). The results of this study validate previous dietary studies that show that consuming small fish bones in the diet improves bone and joint health and that natural fish bone supplements, such as CalGo® (salmon bone collagen calcium), may serve as a superior, bioavailable calcium supplement as compared to other mono-component organic or inorganic calcium supplement powders.
 
The improved effect is likely due to several factors; the presence of calcium in its phosphorus-rich hydroxyapatite form, the presence of bone-supporting micronutrient minerals and their influence on alkaline phosphatase activity and the presence of type II collagen that helps increase DNA synthesis and proliferation and Ca2+ deposition in human osteoblast cells.
 
Hofseth BioCare ASA is introducing Nøre Nutrition AS as its new sales company to focus more on direct B2C sales, and social media marketing. The first product to be launched is "Marint Kalsium", as part of the companies' focus to deliver quality of life to its customers. With the use of CalGo® as its main ingredient, Nøre will have the best calcium available on the market as its first product.
 
Read the full article here: hofsethbiocare.com/upload_images/D2CA82B1D7164AC18C1AA48ED49675F4.pdf 

For further information, please contact:
Roger Hofseth, CEO of Hofseth BioCare ASA
Mob: +47 95147941
E-mail: rh@hofseth-as.no
 
Kai Morten Thuen, CEO of Nøre Nutrition AS
Mob: +47 91638401
E-mail: kmt@hofsethbiocare.no

About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers high-value ingredients and finished products for humans and pets. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, HBC is able to preserve the quality of salmon oil, proteins and calcium, prepared of fresh salmon off-cuts. HBC's objective is to contribute to the efficient use of marine resources and deliver quality products for ingredients and finished consumer products in the nutrition market.
Hofseth BioCare's headquarters are located in Ålesund, Norway with branches in Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange Axess list with ticker "HBC". More information about Hofseth BioCare at www.hofsethbiocare.com and www.facebook.com/hofsethbiocare

About Nøre Nutrition AS:
Nøre is a fully owned B2C sales and marketing company of Hofseth BioCare ASA. The company's strategy is to deliver quality of life to its customers by using HBC ingredients, and developing new exiting and valuable product for its customers. Nøre Nutriotion's headquarter is in Ålesund, Norway. More information at https://www.facebook.com/norenutrition/ and http://nore-nutrition.no/

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.